IDH1 and BRAFV600E mutations are associated with infiltrative gliomas or circumscribed gliomas and glioneuronal tumors, respectively [18, 19], and they are exclusive in most cases [20]. This evidence concerns the gene IDH1 and central nervous system cancer.